会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Endoxifen compositions and methods
    • 内给药组合物和方法
    • US09333190B2
    • 2016-05-10
    • US12515261
    • 2007-11-21
    • Ateeq AhmadShoukath M. AliMoghis U. AhmadSaifuddin SheikhImran Ahmad
    • Ateeq AhmadShoukath M. AliMoghis U. AhmadSaifuddin SheikhImran Ahmad
    • A61K9/20A61K9/28A61K9/48A61K31/138A61K31/35A61K9/00A61K9/127A61K9/19C07D309/10
    • A61K31/138A61K9/0014A61K9/127A61K9/19A61K31/35C07D309/10
    • The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of breast cancer and other breast diseases and diseases susceptible to endoxifen. In particular, the compositions of the present invention include liposomes, complexes, vesicles, emulsions, micelles and mixed micelles of endoxifen in which the compositions further contain any of a variety of neutral or charged lipids and desirably, cholesterol and cholesterol derivatives, sterols, Z- and E-guggulsterones, phospholipids, fatty acids, vitamin D, and vitamin E. The present invention also provides methods of preparing endoxifen. The present invention provides methods for treating and preventing breast cancer and other breast related diseases by administrating novel formulations or compositions comprising a therapeutically effective amount of endoxifen.
    • 本发明提供了含有内皮素的内含物,制剂和脂质体的组合物,这些药剂和制剂的制备方法,以及用于治疗乳腺癌和其它乳腺疾病和对内给药易感染的疾病的制剂和制剂的用途。 特别地,本发明的组合物包括脂质体,复合物,囊泡,乳剂,胶束和内皮素的混合胶束,其中所述组合物还含有任何多种中性或带电荷的脂质,并且期望地,胆固醇和胆固醇衍生物,甾醇,Z - 和戊二酮,磷脂,脂肪酸,维生素D和维生素E.本发明还提供了内皮素的制备方法。 本发明提供了通过施用包含治疗有效量的内皮素的新制剂或组合物来治疗和预防乳腺癌和其它乳腺相关疾病的方法。
    • 5. 发明申请
    • Endoxifen Compositions And Methods
    • 内给药组合物和方法
    • US20100112041A1
    • 2010-05-06
    • US12515261
    • 2007-11-21
    • Ateeq AhmadShoukath M. AliMoghis U. AhmadSaifuddin SheikhImran Ahmad
    • Ateeq AhmadShoukath M. AliMoghis U. AhmadSaifuddin SheikhImran Ahmad
    • A61K31/138A61K9/127A61K9/10C07C213/10A61P35/00C07C215/08A61K9/48A61K9/28
    • A61K31/138A61K9/0014A61K9/127A61K9/19A61K31/35C07D309/10
    • The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of breast cancer and other breast diseases and diseases susceptible to endoxifen. In particular, the compositions of the present invention include liposomes, complexes, vesicles, emulsions, micelles and mixed micelles of endoxifen in which the compositions further contain any of a variety of neutral or charged lipids and desirably, cholesterol and cholesterol derivatives, sterols, Z- and E-guggulsterones, phospholipids, fatty acids, vitamin D, and vitamin E. The present invention also provides methods of preparing endoxifen. The present invention provides methods for treating and preventing breast cancer and other breast related diseases by administrating novel formulations or compositions comprising a therapeutically effective amount of endoxifen.
    • 本发明提供了含有内皮素的内含物,制剂和脂质体的组合物,这些药剂和制剂的制备方法,以及用于治疗乳腺癌和其它乳腺疾病和对内给药易感染的疾病的制剂和制剂的用途。 特别地,本发明的组合物包括脂质体,复合物,囊泡,乳剂,胶束和内皮素的混合胶束,其中所述组合物还含有任何多种中性或带电荷的脂质,并且期望地,胆固醇和胆固醇衍生物,甾醇,Z - 和戊二酮,磷脂,脂肪酸,维生素D和维生素E.本发明还提供了内皮素的制备方法。 本发明提供了通过施用包含治疗有效量的内皮素的新制剂或组合物来治疗和预防乳腺癌和其它乳腺相关疾病的方法。
    • 10. 发明申请
    • Synthesis of Cardiolipin Analogues and Uses Thereof
    • 心磷脂类似物及其用途的合成
    • US20080300418A1
    • 2008-12-04
    • US11667232
    • 2005-11-08
    • Moghis U. AhmadMurali K. UkkalamShoukath M. AliImran Ahmad
    • Moghis U. AhmadMurali K. UkkalamShoukath M. AliImran Ahmad
    • C07F9/202
    • C07F9/106
    • The invention provides novel synthetic methodologies for preparing cardiolipin, migrated caridiolipin (1,2-positional isomer of cardiolipin) and their analogues having varying fatty acids and/or alkyl chains with varying length and degrees of saturation/unsaturation. The method comprises (a) reacting an optically pure 1,2-O-dialkyl-sn-glycerol or 1,2-O-dialkyl-sn-glycerol with one or more phosphoramidite reagent(s), wherein a phosphite triester is produced; (b) coupling the product of (a) with glycerol, wherein a protected cardiolipin is produced; and (c) deprotecting the protected cardiolipin, such that cardiolipin is prepared. The cardiolipins and analogues thereof, prepared by the present methods, can be incorporated into liposomes, which can also include active agents such as hydrophobic or hydrophilic drugs, antisense nucleotides or diagnostic agents. Such liposomes can be used to treat diseases or can be used in diagnostic and/or analytical assays.
    • 本发明提供了新的合成方法,用于制备心磷脂,迁移的卡立二磷(心磷脂的1,2位异构体)及其类似物,其具有不同长度和饱和度/不饱和度变化的脂肪酸和/或烷基链。 该方法包括(a)使光学纯的1,2-O-二烷基-sn-甘油或1,2-二烷基-sn-甘油与一种或多种亚磷酰胺试剂反应,其中产生亚磷酸三酯; (b)将(a)的产物与甘油偶联,其中产生受保护的心磷脂; 和(c)使保护的心磷脂脱保护,使得制备心磷脂。 通过本发明方法制备的心磷脂及其类似物可以掺入脂质体中,脂质体还可以包括活性剂如疏水或亲水药物,反义核苷酸或诊断剂。 这样的脂质体可用于治疗疾病或可用于诊断和/或分析测定。